 |
|||
| DERM UPDATE 2004 | |||
| DERM UPDATE 2003 | |||
| DERM UPDATE 2002 | Speakers | ||
| REGISTRATION | Abstract Link | ||
| CONTACT | Comments/Feedback | ||
| HOME | Sponsor List |
DERMATOLOGY 2003 • SCHEDULE OF EVENTS
Thursday, November 6, 2003 – Salle de Bal Centre
2:00 – 4:00
The Evolution of Protopic 4:00 – 6:00 The Risk of Venous Thromboembolism in Women on
combined Oral Contraceptives and Cyproterone
Acetate with EthinyloestradiolFriday, November 7, 2003 – Salle de Bal Centre
2:00 – 4:00
Redefining Efficacy in Psoriasis 4:00 – 6:00 Immune Response Modifiers 6:00 – 8:00 Welcome Reception - Salle de Bal Foyer
Saturday, November 8, 2003 – Salle de Bal Centre
SESSION 1
Chair: Dr. Harvey Lui 7:30 – 8:00 Breakfast 8:00 – 8:05 Opening Remarks Dr. Harvey Lui 8:05 – 8:20 Review of Drugs for the Treatment of of Skin Disease Dr. Stuart Maddin 8:20 – 8:35 Intravenous Immunoglobulin (IVIG) Use in Dermatology in Canada Dr. Neil Shear 8:35 – 8:50 Immune Response Modifiers Dr. Abel Torres 8:50 – 9:05 Calcineurin Inhibitor Therapy vs. Standard of Care & Efficacy Differences Dr. Alan Fleischer 9:05 – 9:20 Preventing Flares: The Long-Term Management Goal in Atopic Eczema Prof. Michael Meurer 9:20 – 9:40 Panel and Questions 9:40 – 10:00 Coffee Break and Poster Exhibits
SESSION 2
Chair: Dr. Gordon Searles10:00 – 10:15 Oral Tazarotene in the Treatment of Psoriasis Dr. Kim Papp 10:15 – 10:30 Alefacept: Redefining Efficacy for Psoriasis Dr. Michael Goldfarb 10:30 – 10:45 Emerging Role of Calcipotriol in Psoriasis Dr. Lyn Guenther 10:45 – 11:00 Infliximab: A Report on Its Usefulness in the Treatment of Psoriasis Dr. Ian Landells 11:00 – 11:15 Optimising Treatment of Atopic Dermatitis: The Emollient to Topical Steroid Prescribing Ratio Dr. Michael J. Cork 11:15 – 11:35 Panel and Questions
RAPID FIRE LUNCH
Chair: Dr. Chuck Lynde11:45 – 1:30 1. The Role of the Biologics for the Treatment of Psoriasis Dr. Chuck Lynde 2. Constructive Hints in Electrodessication & Curettage Dr. Mariusz Sapijaszko 3. Why is Isotretinoin so Effective? Dr. Rod Kunynetz 4. Botulinum Nuerotoxin Breast Lift Dr. Kevin Smith 5. Dermatologic Drugs and the Pregnant Patient: Do’s and Don’ts Dr. Marni Wiseman 6. Can we count on Acne Counts? Dr. Jerry Tan
SESSION 3
Chair: Dr. Neil Shear1:45 – 2:00 Azoles in Dermatology Dr. Geert Cauwenbergh 2:00 – 2:15 Thalidomide in Dermatology Dr. David Stirling 2:15 – 2:30 Hydroxy Acids, N-Acetylamino Acids and Derivatives Dr. Eugene Van Scott 2:30 – 2:45 Retinoids in Dermatology: An interesting past and a bright future 2:45 – 3:05 Panel and Questions 3:05 - 3:25 Coffee Break and Poster Exhibits
SESSION 4
Chair: Dr. Robert Bissonnette3:25 – 3:40 Comparative Clinical Effectiveness of Hormonal Therapy in Acne: Interim Results from the Canadian Acne Epidemiological Survey Dr. Jerry Tan 3:40 – 4:00 Advances in Pathophysiology of Acne Dr. Brigitte Dren 4:00 – 4:20 The New Global Alliance Consensus Recommendations: Implications for the Management of Acne Therapy in Canada Dr. Neil Shear 4:20 – 4:35 Hormonal Management of Hirsutism Dr. Jerry Shapiro 4:35 – 4:50 Practice Changes in Dermatology Over the Next Five Years Dr. Dana Hanson 4:50 – 5:05 Panel and Questions 5:05 – 5:15 Closing Comments Dr. Stuart Maddin